The efficacy and safety of direct-acting antiviral agents in patients with chronic HCV infection and UGT1A1*28 polymorphism

by Lukashyk S.P., Karpov I.A., Siniauskaya M.G., Danilenko N.G., Anisko L.A., Davydenko O.G., Krasko O.V.
Published 2020-03-01

Diagnosis treatment and prophylaxis of community-acquired bacterial meningitis: the review of the guidelines of European Society for Clinical Microbiology and Infectious Diseases

by Solovey N.V., Karpov I.A., Davydov A.V., Scherba V.V., Danilov D.E., Anisko L.A., Reshetnik V.V., Rogacheva T.A., Zhlobovich I.N.
Published 2017-05-01